Dosage adjustment of vancomycin in continuous infusion in critically ill-patients;Ajustement de la posologie de la vancomycine administrée en perfusion continue chez des patients de réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 1, 2010, Pages 55-57

  Carricajo, A ^a   Forgeot, A ^a   Morel, J ^a   Auboyer, C ^a   Zeni, F ^a   Aubert, G ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

ASC CMI; AUC; Dosage; Serum concentration; Vancomycin; Vancomycine

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG EFFICACY; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; CLINICAL PROTOCOLS; CRITICAL CARE; CRITICAL ILLNESS; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HOSPITALS, UNIVERSITY; HUMANS; INFUSIONS, INTRAVENOUS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RECOVERY ROOM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; VANCOMYCIN;

EID: 77349091306     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2009.12.002     Document Type: Article

References (13)

1. Helgason K.O., Thomson A.H., Ferguson G. A review of vancomycin therapeutic drug monitoring recommendations in Scotland. J Antimicrob Chemother 2008, 61:1398-1399.
2. Wysocki M., Delatour F., Faurisson F., Rauss A., Pean Y., Misset B., et al. Continuous intermittent infusion of vancomycin in severe Staphylococcal infections: Prospective randomized study. Antimicrob Agents Chemother 2001, 45:2460-2467.
3. Goldstein F.W., Kitzis M.D. Vancomycin-resistant Staphylococcus aureus: no apocalypse now. Clin Infect Dis 2003, 9:761-765.
4. Kumar A., Roberts D., Wood K., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
5. Gauzit R. le Club d'infectiologie en anesthesie réanimation (CIAR) et le laboratoire Aventis. Utilisation des glycopeptides en anesthésie réanimation. Ann Fr Anesth Reanim 2002, 21:414-417.
6. Rybak M., Lomaestro B., Rotschafer J.C., Moellering R., Craig W., Billeter M., et al. Therapeutic monitoring of vancomycin in adult poatients consensus revue of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 2009, 66:82-98.
7. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
8. Lodise T.P., Lomaestro B., Graves J., Drusano G.L. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008, 52:1130-1136.
9. Wang G., Hindler J.F., Ward K.W., Bruckner D.A. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006, 44:3883-3886.
10. Soriano A., Marco F., Martinez J.A., Pisos E., Almela M., Dimova V.P., et al. Influence of vancomycin inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46:193-200.
11. Moise P.A., Forrest A., Bhavnani S.M., Birmingham M.C., Chantag J.J. Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus. Am J Health-Syst Pharma 2000, 57:S4-S9.
12. Wang J.T., Fang C.T., Chen Y.C., Chang S.C. Necessity of a loading dose when using vancomycin in critically ill-patients. J Antimicrob Chemother 2001, 47:246.
13. Roberts J.A., Lipmann J. Pharmacokinetic issues for antibiotics in the critically ill-patient. Crit Care Med 2009, 37:840-851.